Prolactin and estradiol serum levels in unmedicated male paranoid schizophrenia patients

被引:33
作者
Segal, Michael [1 ]
Avital, Avi
Berstein, Severina
Derevenski, Andrei
Sandbank, Sergio
Weizman, Abraham
机构
[1] Fhugelmans Mazra Mentral Hlth Med Ctr, IL-25201 Akko, Israel
[2] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel
[3] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel
[4] Max Stern Acad Coll, Emek Yezreel, Israel
[5] Rebeca Sieff Hlth Med Ctr, Safed, Israel
[6] Geha Psychiat Hosp, Res Unit, Petah Tiqwa, Israel
[7] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
estradiol; nonparanoid; paranoid; prolactin; schizophrenia subtypes;
D O I
10.1016/j.pnpbp.2006.09.016
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is evidence for the involvement of the endocrine system in schizophrenia. This involment was widely investigated in female patients. In the current study, we examined prolactin and estradiol serum levels in hospitalized unmedicated men with first-episode and recurrent schizophrenia and then tested possible correlation with various subtypes of the disease. In addition, the estradiol and prolactin levels were compared with a healthy control group. The serum samples were assessed the morning following admission in fifty-seven schizophrenia male patients. There was a significant difference in prolactin serum levels between the paranoid and "nonparanoid" schizophrenia subgroups. However, no significant differences were found in estradiol serum levels between schizophrenia subtypes or between the patients and their healthy counterparts. Finally, a significant and positive correlation was found between the prolactin and estradiol levels in the paranoid subgroup alone. Thus, it appears that low estradiol levels are associated with low prolactin levels, alleged hyperdopaminergic tone and psychotic breakdown in paranoid schizophrenia. The results of the present study further support our previous report of the association between prolactin serum levels and the schizophrenia cluster subtypes, indicating a different dopaminergic activity for the various forms of the disease. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:378 / 382
页数:5
相关论文
共 42 条
  • [1] *AB LAB, 1997, AXSYM PROL ASS A MIC
  • [2] *ABB LAB DIAGN DIV, 2001, AXSYM ESTR ASS, P1
  • [3] Sex differences in the risk of schizophrenia - Evidence from meta-analysis
    Aleman, A
    Kahn, RS
    Selten, JP
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (06) : 565 - 571
  • [4] [Anonymous], 1994, AM PSYCHIATR ASSOC
  • [5] Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics
    Bergemann, N
    Mundt, C
    Parzer, P
    Jannakos, I
    Nagl, I
    Salbach, B
    Klinga, K
    Runnebaum, B
    Resch, F
    [J]. SCHIZOPHRENIA RESEARCH, 2005, 73 (2-3) : 357 - 366
  • [6] Cyr M, 2002, J PSYCHIATR NEUROSCI, V27, P12
  • [7] DAVIS BM, 1985, ARCH GEN PSYCHIAT, V42, P259
  • [8] Di Paolo T, 1994, Rev Neurosci, V5, P27
  • [9] EFFECT OF PROLACTIN AND ESTRADIOL ON RAT STRIATAL DOPAMINE-RECEPTORS
    DIPAOLO, T
    POYET, P
    LABRIE, F
    [J]. LIFE SCIENCES, 1982, 31 (25) : 2921 - 2929
  • [10] EFFECT OF CHRONIC ESTRADIOL AND HALOPERIDOL TREATMENT ON STRIATAL DOPAMINE-RECEPTORS
    DIPAOLO, T
    POYET, P
    LABRIE, F
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1981, 73 (01) : 105 - 106